Dr. Ravi Ramjesingh, MD

Claim this profile

Nova Scotia Cancer Centre

Studies Blood Clot
Studies Hepatocellular Carcinoma
1 reported clinical trial
2 drugs studied

Area of expertise

1Blood Clot
Ravi Ramjesingh, MD has run 1 trial for Blood Clot. Some of their research focus areas include:
Stage II
Stage I
2Hepatocellular Carcinoma
Ravi Ramjesingh, MD has run 1 trial for Hepatocellular Carcinoma. Some of their research focus areas include:
Stage II
Stage I

Clinical Trials Ravi Ramjesingh, MD is currently running

Image of trial facility.

Atezolizumab + Bevacizumab vs Radiation Therapy

for Liver Cancer

A multicentre, parallel group, randomized controlled Phase II clinical trial evaluating neoadjuvant Atezolizumab/Bevacizumab versus neoadjuvant SBRT in patients with biopsy proven solitary HCC with PVTT involving the portal vein branches. Both arms are considered experimental, and as such, a Simon two-stage design will be initially used within both arms. Only if both arms are deemed of interest for further study will a comparison between arms, using a pick-the-winner design, be conducted. Following the completion of neoadjuvant therapy, study participants will undergo a CT scan or MRI to assess tumour response to neoadjuvant therapy. Hepatic resection will be performed for those participants who meet the surgical resection criteria.
Recruiting1 award Phase 25 criteria

More about Ravi Ramjesingh, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Ravi Ramjesingh, MD has experience with
  • Atezolizumab/Bevacizumab
  • SBRT
Breakdown of trials Ravi Ramjesingh, MD has run
Blood Clot
Hepatocellular Carcinoma
Cancer
Liver Cancer
Portal Vein Tumour Thrombosis

Other Doctors you might be interested in

Nikhilesh Patil, MDNova Scotia Cancer Centre

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ravi Ramjesingh, MD specialize in?
Ravi Ramjesingh, MD focuses on Blood Clot and Hepatocellular Carcinoma. In particular, much of their work with Blood Clot has involved Stage II patients, or patients who are Stage I.
Is Ravi Ramjesingh, MD currently recruiting for clinical trials?
Yes, Ravi Ramjesingh, MD is currently recruiting for 1 clinical trial in Halifax Nova Scotia. If you're interested in participating, you should apply.
Are there any treatments that Ravi Ramjesingh, MD has studied deeply?
Yes, Ravi Ramjesingh, MD has studied treatments such as Atezolizumab/Bevacizumab, SBRT.
What is the best way to schedule an appointment with Ravi Ramjesingh, MD?
Apply for one of the trials that Ravi Ramjesingh, MD is conducting.
What is the office address of Ravi Ramjesingh, MD?
The office of Ravi Ramjesingh, MD is located at: Nova Scotia Cancer Centre, Halifax, Nova Scotia Canada. This is the address for their practice at the Nova Scotia Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top